Canopy Growth Corporation

General ticker "CGC" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $397.0M (TTM average)

Canopy Growth Corporation does not follow the US Stock Market performance with the rate: -19.6%.

Estimated limits based on current volatility of 3.5%: low 0.51$, high 0.54$

Factors to consider:

  • Total employees count: 1128 (+17.5%) as of 2026
  • US accounted for 13.8% of revenue in the fiscal year ended 2024-03-31
  • Top business risk factors: Regulatory and compliance, Capital shortage, Integration failure, Agricultural crop failure, Currency fluctuations
  • Current price 14.6% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2026-03-31 to 2028-03-30

  • 2026-03-31 to 2027-03-31 estimated range: [0.59$, 1.31$]
  • 2027-03-31 to 2028-03-30 estimated range: [0.53$, 1.18$]

Similar symbols

Short-term CGC quotes

Long-term CGC plot with estimates

Financial data

YTD 2026-03-31
Operating Revenue CA$284.60MM
Operating Expenses CA$357.71MM
Operating Income CA$-73.11MM
Non-Operating Income CA$-189.78MM
Interest Expense CA$38.19MM
Income(Loss) CA$-262.88MM
Taxes CA$0.02MM
Net Income(Loss)* CA$-262.91MM
Stockholders Equity CA$697.59MM
Inventory CA$154.12MM
Assets CA$1,118.73MM
Operating Cash Flow CA$-63.81MM
Capital expenditure CA$5.95MM
Investing Cash Flow CA$-21.35MM
Financing Cash Flow CA$332.41MM
Earnings Per Share** CA$-0.88

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.